13F HOLDINGS REPORT
B Group, Inc.
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001420506-25-001152
Total Value
$116.7M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ADMA BIOLOGICS INC | ADMA | 2,317,542 | $46.0M | 39.39% |
| 2 | INSMED INC | INSM | 262,500 | $20.0M | 17.16% |
| 3 | ZAI LAB LTD | ZLAB | 400,000 | $14.5M | 12.38% |
| 4 | AKERO THERAPEUTICS INC | 00973Y108 | 242,500 | $9.8M | 8.41% |
| 5 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1,500,000 | $5.0M | 4.28% |
| 6 | CELLECTIS S A | CLLS | 3,256,501 | $4.0M | 3.46% |
| 7 | AURA BIOSCIENCES INC | AURA | 472,576 | $2.8M | 2.37% |
| 8 | SIGHT SCIENCES INC | SGHT | 833,600 | $2.0M | 1.71% |
| 9 | ASSEMBLY BIOSCIENCES INC | ASMB | 200,000 | $1.9M | 1.64% |
| 10 | TAYSHA GENE THERAPIES INC | TSHA | 1,255,556 | $1.7M | 1.50% |
| 11 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 47,500 | $1.7M | 1.47% |
| 12 | BIONTECH SE | BNTX | 15,000 | $1.4M | 1.17% |
| 13 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 37,600 | $1.4M | 1.17% |
| 14 | SPYRE THERAPEUTICS INC | SYRE | 70,000 | $1.1M | 0.97% |
| 15 | APOGEE THERAPEUTICS INC | APGE | 30,000 | $1.1M | 0.96% |
| 16 | PRAXIS PRECISION MEDICINES I | PRAX | 19,000 | $719,530 | 0.62% |
| 17 | 89BIO INC | 282559103 | 95,623 | $695,179 | 0.60% |
| 18 | ORUKA THERAPEUTICS INC | ORKA | 58,215 | $597,286 | 0.51% |
| 19 | CORVUS PHARMACEUTICALS INC | CRVS | 90,000 | $286,200 | 0.25% |